Chiome Bioscience Inc. (TYO:4583)

Chiome Bioscience Balance Sheet

Financials in millions JPY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	1,475	2,063	1,326	1,727	1,791	2,686
Cash & Short-Term Investments	1,475	2,063	1,326	1,727	1,791	2,686
Cash Growth	33.64%	55.65%	-23.26%	-3.56%	-33.33%	27.56%
Accounts Receivable	39.37	51.06	83.19	115.22	25.46	56.78
Other Receivables	16.09	24.43	25.05	29.57	36.05	57.57
Receivables	55.46	75.49	108.24	144.79	61.51	114.35
Inventory	46.67	46.17	64.11	71.48	59.05	89.26
Prepaid Expenses	-	46.66	43.85	57.15	34.47	34.99
Other Current Assets	253.41	106.08	87.65	91.48	270.87	323.6
Total Current Assets	1,830	2,338	1,629	2,092	2,217	3,249
Property, Plant & Equipment	-	-	1.17	2.44	4.2	7.16
Long-Term Investments	-	-	-	-	-	150
Other Long-Term Assets	132.24	131.19	120.89	120.87	118.36	88.88
Total Assets	1,963	2,469	1,751	2,215	2,339	3,495
Accounts Payable	36.83	27.2	37.74	31.87	29.81	40.11
Accrued Expenses	11.43	29.56	32.32	32.91	44.46	36.69
Short-Term Debt	260.5	281.5	291	184	183	180
Current Income Taxes Payable	10.33	2.53	23.95	23.94	16.75	3.24
Other Current Liabilities	68.97	152.65	154.03	97.74	118.53	82.68
Total Current Liabilities	388.06	493.43	539.04	370.46	392.54	342.71
Other Long-Term Liabilities	55.34	55.12	54.69	54.27	53.85	41.87
Total Liabilities	443.4	548.55	593.73	424.72	446.39	384.59
Common Stock	1,066	995.53	2,388	2,097	1,516	1,388
Retained Earnings	444.77	915.02	-1,248	-319.53	342.02	1,694
Treasury Stock	-0.29	-0.29	-0.29	-0.29	-0.29	-0.29
Comprehensive Income & Other	9.3	10.05	17.74	13.55	35.4	28.92
Total Common Equity	1,519	1,920	1,158	1,791	1,893	3,110
Shareholders' Equity	1,519	1,920	1,158	1,791	1,893	3,110
Total Liabilities & Equity	1,963	2,469	1,751	2,215	2,339	3,495
Total Debt	260.5	281.5	291	184	183	180
Net Cash (Debt)	1,214	1,782	1,035	1,543	1,608	2,506
Net Cash Growth	49.65%	72.23%	-32.96%	-4.03%	-35.84%	19.01%
Net Cash Per Share	18.84	30.61	20.88	35.09	39.92	69.85
Filing Date Shares Outstanding	68.04	66.96	52.63	48.42	40.78	39.51
Total Common Shares Outstanding	68.04	66.96	52.63	48.42	40.78	39.51
Working Capital	1,442	1,844	1,090	1,722	1,824	2,906
Book Value Per Share	22.33	28.68	22.00	36.98	46.42	78.72
Tangible Book Value	1,519	1,920	1,158	1,791	1,893	3,110
Tangible Book Value Per Share	22.33	28.68	22.00	36.98	46.42	78.72
Machinery	305.04	312.86	318.96	351.63	387.39	391.26

Source: S&P Global Market Intelligence. Standard template. Financial Sources.